LIDOCAINE, PATCH

The Defense Logistics Agency awarded a delivery order, SPE2DP-26-F-7461, to DMS Pharmaceutical Group Inc. under the basic contract SPE2DX-25-D-9900 for the procurement of two units of lidocaine patches, identified by NSN 6505016572003, at a total contract value of $63.28. The award was issued on July 14, 2026, with delivery required by July 29, 2026, to the designated destination at Fort Campbell, Kentucky. The contract specifies FOB destination terms, meaning the contractor bears all freight costs and risk of loss until delivery. The contractor is a certified small business, small disadvantaged business, and women-owned small business, triggering compliance with applicable small business subcontracting and reporting requirements under FAR. Packaging and marking instructions require all shipments to be sent by the fastest traceable means, excluding parcel post, and must clearly display the base contract number SPE2DX-25-D-9900 and the delivery order number SPE2DP-26-F-7461. Inspection and acceptance are performed by the government at the destination, with no formal quality standards or MIL-STDs cited, relying instead on compliance with contract terms. Payment processing is managed by the Defense Finance and Accounting Service in Columbus, Ohio, under payment code SL4701. Administrative oversight is directed by the DLA Troop Support Medical Supply Chain Pharm FSA in Philadelphia, with Lisa Quinn serving as the contracting officer. No additional clauses, attachments, special requirements, or evaluation factors were explicitly outlined, indicating this is a straightforward, low-value procurement executed under standard DLA supply procedures with minimal administrative overhead.